Evidence map›Paper›PMID 38291236›Full record

ReviewNature reviews. Genetics2024

Inhibitors of bacterial immune systems: discovery, mechanisms and applications.

David Mayo-Muñoz, Rafael Pinilla-Redondo, Sarah Camara-Wilpert, Nils Birkholz, Peter C Fineran

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Revisiting the life cycle of temperate phages.Nature reviews. Microbiology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. A deformableMaterials today. Bio · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Structure and mechanism of antiphage retron Eco2.Nature structural & molecular biology · 2026
    Article
  18. Article
  19. Article
  20. [Research on Bacteriophage Resistance: Coevolutionary Arms Race Between Bacteria and Phages Drives Novel Antibacterial Therapies].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David Mayo-Muñoz *Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID http://orcid.org/0000-0003-0751-4787
Rafael Pinilla-Redondo *Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. rafael.pinilla@bio.ku.dk.ORCID http://orcid.org/0000-0003-3521-460X
Sarah Camara-WilpertSection of Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5713-5326
Nils BirkholzDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID http://orcid.org/0000-0001-5269-5228
Peter C FineranDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. peter.fineran@otago.ac.nz.ORCID http://orcid.org/0000-0002-4639-6704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To contend with the diversity and ubiquity of bacteriophages and other mobile genetic elements, bacteria have developed an arsenal of immune defence mechanisms. Bacterial defences include CRISPR-Cas, restriction-modification and a growing list of mechanistically diverse systems, which constitute the bacterial 'immune system'. As a response, bacteriophages and mobile genetic elements have evolved direct and indirect mechanisms to circumvent or block bacterial defence pathways and ensure successful infection. Recent advances in methodological and computational approaches, as well as the increasing availability of genome sequences, have boosted the discovery of direct inhibitors of bacterial defence systems. In this Review, we discuss methods for the discovery of direct inhibitors, their diverse mechanisms of action and perspectives on their emerging applications in biotechnology and beyond.

Indexed as

BacteriophagesCRISPR-Cas SystemsBacteria

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.